Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Isabel Alvarez-Lopez"'
Autor:
Angela M. Araujo, Andrea Abaurrea, Peio Azcoaga, Joanna I. López-Velazco, Sara Manzano, Javier Rodriguez, Ricardo Rezola, Leire Egia-Mendikute, Fátima Valdés-Mora, Juana M. Flores, Liam Jenkins, Laura Pulido, Iñaki Osorio-Querejeta, Patricia Fernández-Nogueira, Nicola Ferrari, Cristina Viera, Natalia Martín-Martín, Alexandar Tzankov, Serenella Eppenberger-Castori, Isabel Alvarez-Lopez, Ander Urruticoechea, Paloma Bragado, Nicholas Coleman, Asís Palazón, Arkaitz Carracedo, David Gallego-Ortega, Fernando Calvo, Clare M. Isacke, María M. Caffarel, Charles H. Lawrie
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 19 (2022)
Externí odkaz:
https://doaj.org/article/3d06a870071548a9a083041ef64b61ed
Autor:
Ibai Goicoechea, Ricardo Rezola, María Arestin, María M. Caffarel, Ana Rosa Cortazar, Lorea Manterola, Marta Fernandez-Mercado, María Armesto, Carla Sole, Erika Larrea, Angela M. Araujo, Nerea Ancizar, Arrate Plazaola, Ander Urruticoechea, Arkaitz Carracedo, Irune Ruiz, Isabel Alvarez Lopez, Charles H. Lawrie
Publikováno v:
F1000Research, Vol 6 (2018)
Background: The outcome for oestrogen receptor positive (ER+) breast cancer patients has improved greatly in recent years largely due to targeted therapy. However, the presence of involved multiple synchronous lymph nodes remains associated with a po
Externí odkaz:
https://doaj.org/article/f442f153d139472fba8604035732eb6d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Joanna I. López-Velazco, Sara Manzano, María Otaño, Kepa Elorriaga, Núria Bultó, Julio Herrero, Ainhara Lahuerta, Virginia Segur, Isabel Álvarez-López, Maria M. Caffarel, Ander Urruticoechea
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-12 (2024)
Abstract Background Neoadjuvant endocrine therapy (NET) in oestrogen receptor-positive (ER+) /HER2-negative (HER2-) breast cancer allows real-time evaluation of drug efficacy as well as investigation of the biological and molecular changes that occur
Externí odkaz:
https://doaj.org/article/88093a0d7dbb4fc99a956d8953054a31
Autor:
Isabel Tundidor, Marta Seijo-Vila, Sandra Blasco-Benito, María Rubert-Hernández, Sandra Adámez, Clara Andradas, Sara Manzano, Isabel Álvarez-López, Cristina Sarasqueta, María Villa-Morales, Carmen González-Lois, Esther Ramírez-Medina, Belén Almoguera, Antonio J. Sánchez-López, Laura Bindila, Sigrid Hamann, Norbert Arnold, Christoph Röcken, Ignacio Heras-Murillo, David Sancho, Gema Moreno-Bueno, María M. Caffarel, Manuel Guzmán, Cristina Sánchez, Eduardo Pérez-Gómez
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-15 (2023)
Abstract Clinical management of breast cancer (BC) metastasis remains an unmet need as it accounts for 90% of BC-associated mortality. Although the luminal subtype, which represents >70% of BC cases, is generally associated with a favorable outcome,
Externí odkaz:
https://doaj.org/article/ab9e0b407ed94740a55b818db99ef737
Autor:
Oliver Ibarrondo, Garbiñe Lizeaga, José Miguel Martínez-Llorente, Igor Larrañaga, Myriam Soto-Gordoa, Isabel Álvarez-López
Publikováno v:
Gaceta Sanitaria, Vol 36, Iss 3, Pp 246-252 (2022)
Objective: To measure 3-year care costs of breast, prostate, colorectal and lung cancers disaggregated by site and clinical stage. Method: A retrospective observational design was employed to investigate care costs of cases recorded in the Registry o
Externí odkaz:
https://doaj.org/article/ceb40cf0dae04222971d473c403bccab
Autor:
Charles H. Lawrie, María M. Caffarel, Arrate Plazaola, Ander Urruticoechea, Ana R. Cortazar, Carla Solé, Ibai Goicoechea, Isabel Alvarez Lopez, María Armesto, Erika Larrea, Angela M Araujo, Marta Fernandez-Mercado, Nerea Ancizar, Irune Ruiz, Ricardo Rezola, Lorea Manterola, Arkaitz Carracedo, María Arestin
Publikováno v:
F1000Research
Background: The outcome for oestrogen receptor positive (ER+) breast cancer patients has improved greatly in recent years largely due to targeted therapy. However, the presence of involved multiple synchronous lymph nodes remains associated with a po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd2586cfa1d82c062d6137242411833f
https://doi.org/10.12688/f1000research.12393.1
https://doi.org/10.12688/f1000research.12393.1
Autor:
Oliver Ibarrondo, Isabel Álvarez-López, Frederick Freundlich, Arantzazu Arrospide, Elena Galve-Calvo, María Gutiérrez-Toribio, Arrate Plazaola, Javier Mar
Publikováno v:
Gaceta Sanitaria, Vol 34, Iss 1, Pp 61-68 (2020)
Objective: To carry out a cost-utility analysis of the application of the Oncotype genomic test to inform the decision to use or not to use chemotherapy in the Basque Country (Spain). Method: The cost-utility study was carried out using a discrete ev
Externí odkaz:
https://doaj.org/article/13ea16b2bab14802ae397ea669f4de79
Autor:
Ana Isabel Alvarez Lopez, Ignacio Bejarano Hernando, Guillermo Santos Sanchez, Ivan Cruz Chamorro, Eduardo Ponce España, Ivan Parralejo Ayala, Patricia Judith Lardone, Antonio Carrillo Vico
Publikováno v:
IBRO Neuroscience Reports, Vol 15, Iss , Pp S267- (2023)
Externí odkaz:
https://doaj.org/article/ae09295f6b124078bca20d80e56fef34